David Malcom Rodman Mineralys Therapeutics, Inc. (MLYS) insider trading activity

MLYS Quotes by TradingView
Shares Held (Direct Ownership) 141K
23.42% 3M change
836.76% 12M change
Total Value Held N/A

David Malcom Rodman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 11 2023
BUY
Exercise of conversion of derivative security
$2,709 $0.54 p/Share
5,018 Added 20.0%
20,069 Common Stock
Nov 13 2023
BUY
Exercise of conversion of derivative security
$2,709 $0.54 p/Share
5,017 Added 25.0%
15,051 Common Stock
Nov 03 2023
BUY
Exercise of conversion of derivative security
$5,418 $0.54 p/Share
10,034 Added 50.0%
10,034 Common Stock
Aug 11 2023
SELL
Open market or private sale
$2,012,335 $12.81 p/Share
157,091 Reduced 100.0%
0 Common Stock
Aug 11 2023
BUY
Exercise of conversion of derivative security
$127,243 $0.81 p/Share
157,091 Added 67.34%
76,182 Common Stock
Aug 10 2023
SELL
Open market or private sale
$982,065 $13.16 p/Share
74,625 Reduced 100.0%
0 Common Stock
Aug 10 2023
BUY
Exercise of conversion of derivative security
$40,297 $0.54 p/Share
74,625 Added 50.0%
74,625 Common Stock
DMR

David Malcom Rodman

Chief Medical Officer
Radnor, PA

Track Institutional and Insider Activities on MLYS

Follow Mineralys Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MLYS shares.

Notify only if

Insider Trading

Get notified when an Mineralys Therapeutics, Inc. insider buys or sells MLYS shares.

Notify only if

News

Receive news related to Mineralys Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MLYS